Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Expands In Breast Cancer With Talazoparib Approval

Oct 16 2018

• By Mary Jo Laffler

Breast Cancer Awareness: Microscopic image (photomicrograph) of core biopsy for infiltrating (invasive) ductal carcinoma, detected by screening mammogram. H & E stain.

Related Content

Veliparib Phase III Failures Strike Blow To AbbVie's Oncology Strategy

Apr 20 2017

Medivation Hopes Details On Talazoparib Will Inspire Heightened M&A Bidding

Jul 07 2016

Encouraging Survival Data For Lynparza in Metastatic Breast Cancer

Apr 16 2018

CDK4/6 Inhibitor Market Snapshot: New Drugs Jockey For A Piece Of The Multi-Billion Dollar Pie

Jun 19 2018

As A New Rival Approaches, PARP Makers Look To Carve Out Their Niche

Jun 07 2018

Pfizer’s $14bn Medivation Buyout Shows How Far Pharma Will Go In Oncology

Aug 22 2016

Related Companies

Pfizer Inc.

Novartis AG

Eli Lilly and Company

Medivation, Inc.

Johnson & Johnson

Merck KGaA

Myriad Genetics, Inc.

AstraZeneca PLC

Merck & Co., Inc.

Tesaro, Inc.

Clovis Oncology, Inc.

AbbVie Inc.

Additional Topics

United States Approvals Launches Regulation Cancer BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window